Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial.
J Clin Exp Hepatol
; 4(2): 94-100, 2014 Jun.
Article
de En
| MEDLINE
| ID: mdl-25755546
ALD, alcoholic liver disease; ALT, alanine transaminase; ANCOVA, analysis of covariance; AST, aspartate transaminase; ATP, adenosine triphosphate; GGT, gamma-glutamyl transferase; GSH, glutathione; HOMA-IR, homeostasis model assessment for insulin resistance; ITT, intention to treat; MRI, magnetic resonance imaging; MRS, MR spectroscopy; NADH, nicotinamide adenine dinucleotide; NAFLD, non-alcoholic fatty liver disease; NASH; NASH, non-alcoholic steatohepatitis; PDFF, proton-density fat-fraction; RCTs, randomized clinical trials; RIQ, range interquartile; TNF, tumor necrosis factors; controlled clinical trial; metadoxine
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Clinical_trials
/
Prognostic_studies
Langue:
En
Journal:
J Clin Exp Hepatol
Année:
2014
Type de document:
Article
Pays d'affiliation:
Inde